News

Neuropharmatest Interview 20 de Noviembre de 2013

Javier Gilabert, founding partner of neuropharmatest has been interviewed by Infocif. http://noticias.infocif.es/noticia/jovenes-emprendedores-y-sobradamente-preparados

Awards!! 14 de Noviembre de 2013

Neuropharmatest project receives the 2nd award in "Valencia Emprende" and the 1st in the R+D category in the "Emprenjove Awards"

New Website! 15 de Octubre de 2013

We are happy to present our new website, we hope you like and enjoy their content. Do not forget to follow us on Twitter and Facebook to stay abreast of our news. Thank you very much.

Award! 13 de Diciembre de 2012

Neuropharmatest project receives the “Bancaja Young Entrepeneur Award”

Neuropharmatest Selected 01 de Diciembre de 2012

Neuropharmatest selected among the 11 projects to participate in the investment forum of the bioentrepreneurs program “BIOCAMPUS 2012” of Genoma España.

Alicia Koplowitz Foundation Award 10 de Septiembre de 2012

Neuropharmatest scientists awarded a project from the Alicia Koplowitz Foundation to study the influence of cannabis consumption on the development of schizophrenia using an animal model of this disorder.

Valencia Emprende 2012 01 de Septiembre de 2012

Neuropharmatest selected to receive a “launching grant” from “Itinerario emprendedor” of Valencia Emprende
Neuropharmatest selected to participate in the bioentrepreneurs program “BIOCAMPUS 2012” of Genoma España.

Support

Neuropharmatest Emprenjove
Neuropharmatest Biocampus
Neuropharmatest Premios Bancaja
Neuropharmatest Valencia Emprende

Our Offer | Our Platform

Our Offer

Neuropharmatest scientists can design for you the best set of experiments directed to provide you with a solid evidence of the action of your experimental treatment on the central nervous system of control animals and on animal models of neurological and psychiatric disorders.

We can perform a complete set of analyses or apply only selected tests “à la carte”. 

Our analyses can be applied to different species of animals. We can use commercial animals, generate them in our animal facility or work with animals generated by the client. We apply pharmacological treatments using commercial drugs or drugs provided by the client. We have experience in different routes of administration and we can use different doses, treatment durations...etc. 

We generate and evaluate different animal models of psychiatric and neurological disorders. These models can be subjected to pharmacological treatments and subsequently evaluated. * Fast and reliable results and a competitive price.


Our Platform

Neuropharmatest is a platform  developed by the Neurobiology Unit of the University of València, a research group devoted to the study of neuronal plasticity since  1996.  

After working more than fifteen years in the field, we have developed a comprehensive battery of tests directed to evaluate several parameters indicative of neural plasticity in the brain of adult mammals. 

We offer our services pharmaceutical companies and to research laboratories interested in evaluating at the preclinical level the efficacy of drugs and other treatments on neurochemical, structural and behavioral parameters.

We have experience in applying this battery of tests for the study of the action of antidepressants, antipsychotics and other drugs with an important impact on the CNS. We have also ample experience in applying these tests on different animal models of psychiatric and neurological disorders and in animal models of metabolic diseases (see Disease models).